Anti-TNF alpha in the treatment of psoriatic arthritis

被引：5
|
作者：
Claudepierre, P
Wendling, D
Cohen, JD
机构：
[1] CHU Henri Mondor, Serv Rhumatol, F-94010 Creteil, France
[2] CHU Jean Mindoz, Serv Rhumatol, Besancon, France
来源：
PRESSE MEDICALE | 2006年 / 35卷 / 04期
关键词：
D O I：
10.1016/S0755-4982(06)74658-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Psoriatic arthritis is on inflammatory and possibly destructive form of arthritis. As in rheumatoid arthritis and ankylosing spondylitis, the use of biological therapy in psoriatic arthritis is a therapeutic revolution: both articular and cutaneous efficacy have been shown, and some improvement is visible on radiography. The benefit-risk ratio will improve when we learn to identify more accurately the patients likely to benefit from these treatments.
引用
收藏
页码：647 / 655
页数：9
相关论文
共 50 条
  • [1] Adalimumab: an anti-TNF agent for the treatment of psoriatic arthritis
    Mease, PJ
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2005, 5 (11) : 1491 - 1504
  • [2] Safety of anti-TNFα agents in the treatment of psoriasis and psoriatic arthritis
    Girolomoni, Giampiero
    Altomare, Gianfranco
    Ayala, Fabio
    Berardesca, Enzo
    Calzavara-Pinton, Piergiacomo
    Chimenti, Sergio
    Peserico, Andrea
    Guerra, Antonio Puglisi
    Vena, Gino Antonio
    [J]. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2012, 34 (04) : 548 - 560
  • [3] Frequency of autoimmune thyroid disorders in patients with psoriatic arthritis and effect of anti-TNF alpha treatment
    Karaogullarindan, Umit
    Tarhan, Emine Figen
    Oruk, Gonca
    [J]. CUKUROVA MEDICAL JOURNAL, 2020, 45 (02): : 461 - 467
  • [4] Psoriatic arthritis: an update on anti-TNF therapy
    Glintborg, B.
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2012, 41 : 4 - 4
  • [5] Anti-TNF alpha in the treatment of rheumatoid arthritis and ankylosing spondylitis
    Lanfant-Weybel, Karine
    Lequerre, Thierry
    Vittecoq, Olivier
    [J]. PRESSE MEDICALE, 2009, 38 (05): : 774 - 787
  • [6] Autoantibodies in patients with psoriatic arthritis on anti-TNFα therapy
    Viana, Vilma S. Trindade
    de Carvalho, Jozelio Freire
    Bertacini de Moraes, Julio Cesar
    Schain Saac, Carla Goncalves
    de Medeiros Ribeiro, Ana Cristina
    Goncalves, Celio
    Bueno, Cleonice
    Vendramini, Margarete B.
    Bonfa, Eloisa
    [J]. REVISTA BRASILEIRA DE REUMATOLOGIA, 2010, 50 (03) : 230 - 234
  • [7] POLYMORPHISMS ASSOCIATED WITH ANTI-TNF RESPONSE IN PSORIATIC ARTHRITIS
    Ovejero-Benito, M. C.
    Munoz-Aceituno, E.
    Reolid, A.
    Prieto-Perez, R.
    Hevia, L.
    Abad-Santos, F.
    Dauden, E.
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 123 : 89 - 89
  • [8] Drug resistance in anti-TNF therapy of psoriatic arthritis
    Wcislo-Dziadecka, Dominika Ligia
    Grabarek, Benjamin
    Brzezinska-Wcislo, Ligia
    Mazurek, Urszula
    [J]. PRZEGLAD DERMATOLOGICZNY, 2018, 105 (05): : 625 - 631
  • [9] Biologic therapies different from the anti-TNF alpha therapy in psoriasis and psoriatic arthritis
    Queiro Silva, Ruben
    Alonso Castro, Sara
    Ballina Garcia, Javier
    [J]. REUMATOLOGIA CLINICA, 2010, 6 : 41 - 46
  • [10] Treatment patterns and costs for anti-TNFα biologic therapy in patients with psoriatic arthritis
    Palmer, Jacqueline B.
    Li, Yunfeng
    Herrera, Vivian
    Liao, Minlei
    Tran, Melody
    Ozturk, Zafer E.
    [J]. BMC MUSCULOSKELETAL DISORDERS, 2016, 17
12345